Day 3 Program

State of the Art 2: Targeting the Non-T Cell Microenvironment

Day 3: December 11, 2025

1:00 PM–2:15 PM CST

Stars at Night 3-4

Session Details

SA2-01

Fibroblast and immunosuppression in breast cancer

Fatima Mechta-Grigoriou, Institut Curie, Paris, France

SA2-02

Role of macrophage reprograming in breast cancer outcomes

Lisa Coussens, Oregon Health & Science University, Portland, OR

SA2-03

Targeting non T-cells in the clinic

George Plitas, Memorial Sloan Kettering Cancer Center, New York, NY

Advocate

Cheryl Jernigan, Kansas Institute for Precision Medicine, Kansas City, KS